Helical nanoparticles trigger cancer alarms and deliver gene therapy

Cancer cells survive by hiding from the immune system's surveillance.

A KAIST research team has developed a new anticancer platform that makes cancer cells send out their own danger signals—prompting immune cells to attack—while simultaneously delivering gene therapy.

The approach is expected to offer a new treatment strategy that combines cancer immunotherapy and gene therapy in a single nanoparticle. ...